Liver Diseases  >>  otamixaban (XRP0673)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
otamixaban (XRP0673) / Sanofi
NCT01126086: Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild and Moderate Hepatic Impairment

Completed
1
25
US
otamixaban XRP0673
Sanofi
Hepatic Impairment
04/11
04/11

Download Options